Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study

被引：0
|
作者：
Ohoud Aljuhani
Khalid Al Sulaiman
Adel Alshabasy
Khalid Eljaaly
Abdulrahman I. Al Shaya
Haytham Noureldeen
Mohammed Aboudeif
Bodoor Al Dosari
Amina Alkhalaf
Ghazwa B. Korayem
Muneera M. Aleissa
Hisham A. Badreldin
Shmeylan Al Harbi
Abdullah Alhammad
Ramesh Vishwakarma
机构：
[1] King Abdulaziz University,Department of Pharmacy Practice, Faculty of Pharmacy
[2] King Abdulaziz Medical City,Pharmaceutical Care Department
[3] King Abdulaziz University,Department of Anesthesia and Intensive Care
[4] King Saud Bin Abdulaziz University for Health Sciences,College of Pharmacy
[5] King Abdullah International Medical Research Center,Pharmaceutical Care Department
[6] King Abdulaziz University Hospital,College of Pharmacy
[7] Princess Nourah Bint Abdulrahman University,Department of Clinical Pharmacy, College of Pharmacy
[8] King Saud University,College of Pharmacy
[9] University of Arizona,Department of Anesthesia and Intensive Care
[10] Brigham and Women’s Hospital,undefined
[11] Ain Shams University,undefined
来源：
BMC Infectious Diseases | / 21卷
关键词：
COVID-19; SARS-Cov-2; Tocilizumab; Secondary infection; CRE; Critically ill; Intensive care units (ICUs); Immunomodulatory drugs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study
    Wu, Ming
    Ji, Jing-jing
    Zhong, Li
    Shao, Zi-yun
    Xie, Qi-feng
    Liu, Zhe-ying
    Wang, Cong-lin
    Su, Lei
    Feng, Yong-wen
    Liu, Zhi-feng
    Yao, Yong-ming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 88
  • [12] Association Between Multidrug-Resistant Bacteria and Mortality in Critically Ill Patients
    Duclos, Gary
    Lakbar, Ines
    Boucekine, Mohamed
    Lolo, Georges
    Cassir, Nadim
    Leone, Marc
    ADVANCES IN THERAPY, 2023, 40 (04) : 1736 - 1749
  • [13] Association Between Multidrug-Resistant Bacteria and Mortality in Critically Ill Patients
    Gary Duclos
    Ines Lakbar
    Mohamed Boucekine
    Georges Lolo
    Nadim Cassir
    Marc Leone
    Advances in Therapy, 2023, 40 (4) : 1736 - 1749
  • [14] Tocilizumab in critically ill COVID-19 patients: An observational study
    Mushtaq, Muhammad Z.
    Mahmood, Saad B. Z.
    Almas, Aysha
    Wasti, Syed Ather
    Ali, Syed Ahsan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 102
  • [15] Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study
    Yiming Li
    Qinghe Meng
    Xin Rao
    Binbin Wang
    Xingguo Zhang
    Fang Dong
    Tao Yu
    Zhongyi Li
    Huibin Feng
    Jinpeng Zhang
    Xiangyang Chen
    Hunian Li
    Yi Cheng
    Xiaoyang Hong
    Xiang Wang
    Yimei Yin
    Zhongheng Zhang
    Dawei Wang
    Critical Care, 24
  • [16] Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study
    Li, Yiming
    Meng, Qinghe
    Rao, Xin
    Wang, Binbin
    Zhang, Xingguo
    Dong, Fang
    Yu, Tao
    Li, Zhongyi
    Feng, Huibin
    Zhang, Jinpeng
    Chen, Xiangyang
    Li, Hunian
    Cheng, Yi
    Hong, Xiaoyang
    Wang, Xiang
    Yin, Yimei
    Zhang, Zhongheng
    Wang, Dawei
    CRITICAL CARE, 2020, 24 (01)
  • [17] Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
    Gupta, Shruti
    Wang, Wei
    Hayek, Salim S.
    Chan, Lili
    Mathews, Kusum S.
    Melamed, Michal L.
    Brenner, Samantha K.
    Leonberg-Yoo, Amanda
    Schenck, Edward J.
    Radbel, Jared
    Reiser, Jochen
    Bansal, Anip
    Srivastava, Anand
    Zhou, Yan
    Finkel, Diana
    Green, Adam
    Mallappallil, Mary
    Faugno, Anthony J.
    Zhang, Jingjing
    Velez, Juan Carlos Q.
    Shaefi, Shahzad
    Parikh, Chirag R.
    Charytan, David M.
    Athavale, Ambarish M.
    Friedman, Allon N.
    Redfern, Roberta E.
    Short, Samuel A. P.
    Correa, Simon
    Pokharel, Kapil K.
    Admon, Andrew J.
    Donnelly, John P.
    Gershengorn, Hayley B.
    Douin, David J.
    Semler, Matthew W.
    Hernan, Miguel A.
    Leaf, David E.
    JAMA INTERNAL MEDICINE, 2021, 181 (01) : 41 - 51
  • [18] Sedation and analgesia in critically ill patients with COVID-19: a cohort retrospective study
    Aurilio, Caterina
    Corcione, Antonio
    Fraganza, Fiorentino
    Sansone, Pasquale
    Paladini, Antonella
    Passavanti, Maria Beatrice
    Pota, Vincenzo
    Coppolino, Francesco
    Molino, Francesca
    Pace, Maria Caterina
    SIGNA VITAE, 2021, 17 (05) : 52 - 57
  • [19] The Impact of Multidrug-Resistant Acinetobacter baumannii Infection in Critically Ill Patients with or without COVID-19 Infection
    Alenazi, Thamer A.
    Shaman, Maryam S. Bin
    Suliman, Durria M.
    Alanazi, Turkiah A.
    Altawalbeh, Shoroq M.
    Alshareef, Hanan
    Lahreche, Doha I.
    Al-Azzam, Sayer
    Araydah, Mohammad
    Karasneh, Reema
    Rebahi, Faycal
    Alharbi, Marwah H.
    Aldeyab, Mamoon A.
    HEALTHCARE, 2023, 11 (04)
  • [20] CLINICAL COURSE OF 195 CRITICALLY ILL COVID-19 PATIENTS: A RETROSPECTIVE MULTICENTER STUDY
    Zhou, Shuliang
    Yang, Yadong
    Zhang, Xingguo
    Li, Zhifeng
    Liu, Xing
    Hu, Chang
    Chen, Chunxi
    Wang, Dawei
    Peng, Zhiyong
    SHOCK, 2020, 54 (05): : 644 - 651
12345